Boundless Bio Ownership | Who Owns Boundless Bio?

Boundless Bio Ownership Summary

Boundless Bio is owned by 193.46% institutional investors.

BOLD Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Boundless Bio	193.46%	-	-93.46%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2019	210	39.07%	43,024,371	-3.54%	193	0.48%	134	61.45%	39	8.33%
Sep 30, 2019	151	0.67%	44,605,089	-0.11%	200	0.50%	83	-10.75%	36	2.86%
Jun 30, 2019	150	5.63%	44,652,015	2.13%	200	0.52%	93	22.37%	35	-12.50%
Mar 31, 2019	142	10.08%	43,722,202	1.41%	196	0.52%	76	-6.17%	40	33.33%
Dec 31, 2018	129	10.26%	43,113,873	19.33%	193	0.73%	81	47.27%	30	-3.23%

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 08, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$432.78K
Aug 12, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$34.52K
Aug 12, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$646.31K
Feb 25, 2019	Patterson Matthew R	Chief Executive Officer	Sell	$120.00K
Oct 01, 2018	Patterson Matthew R	Chief Executive Officer	Sell	$202.73K

BOLD Ownership FAQ

Who Owns Boundless Bio?

Boundless Bio shareholders are primarily institutional investors at 193.46%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Boundless Bio's industry, Biotech Stocks , is 47.04%, which Boundless Bio exceeds.

Does Blackrock own Boundless Bio?

BlackRock is not among the top 10 institutional shareholders of Boundless Bio.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools